Edwards Lifesciences to buy Israel's Valtech for up to $690 million: Reuters

Edwards Lifesciences Corp (EW.N) on Monday said it has agreed to buy Israel's Valtech Cardio for $340 million in stock and cash, with the potential for an additional $350 million in pre-specified milestone-driven payments over the next 10 years.

DealsNorth AmericaUSBriefs